APP and Alzheimer disease: In addition, APP transgenic models with a C-terminus cleavage site mutation which prevents the cleavage of AICD showed a complete reversal of AD phenotypes susceptibility to induced-seizure [34,35,36], suggesting that AICD might be the excitotoxic fragment of APP that contributes to the development of AD phenotypes and seizures in AD models.